Skip to content
1M1B Changemakers
  • Home
  • 1M1B
    • Flaunch
    • Hypershift
  • Changemakers
  • Blogs
    • Trending
    • Impact
  • Contact Us
  • Toggle website search
Menu Close
  • Home
  • 1M1B
  • Flaunch
  • Hypershift
  • Changemakers
  • Blogs
  • Trending
  • Impact
  • Contact Us

Hetero

  1. Home>
  2. Blog>
  3. Hetero
Dr Reddy’s, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir – Times of India

Dr Reddy’s, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir – Times of India

  • Post author:1m1bchangemakers
  • Post published:October 2, 2024
  • Post category:Business
  • Post comments:0 Comments

Dr Reddy’s Laboratories HYDERABAD: Dr Reddy’s Laboratories and Hetero are among half a dozen generic drug makers to have entered into non-exclusive, royalty-free voluntary licencing agreements with Gilead Sciences Ireland…

Continue ReadingDr Reddy’s, Hetero ink royalty-free voluntary licencing pacts with Gilead Sciences for HIV drug Lenacapavir – Times of India

Trending Category

  • Blogs
  • Business
  • Education
  • Top Stories
  • Trending

Recent Posts

  • Daily Debrief: What Happened Today (Aug 8)
  • Indian Navy recruitment drive 2025: Notification released for 1,266 Civil Tradesman posts, registration begins on this date – Times of India
  • Gold rate today: Gold prices surge to over Rs 1.02 lakh per 10 grams; what’s the outlook? – Times of India
  • India-US trade deal: With Donald Trump’s 50% tariffs looming, India reviews market access offers for US; three-pronged strategy to protect exporters – Times of India
  • NEET UG 2025 round 1 seat allotment results to be released tomorrow: Check steps to download and other important details – Times of India
All rights reserved © 2023 1M1B.